In the study, a once-daily, single-tablet combination of bictegravir and lenacapavir was as effective as Gilead's existing ...

Howard County will dispense the biannual prevention injection Yeztugo, a less time-consuming option than current preventative ...

This year has been one for the books in medicine. From Ozempic’s expanded role in protecting failing kidneys to long‑acting ...

Gilead Sciences’ human immunodeficiency virus (HIV) single-tablet combination antiretroviral therapy (ART) has proven ...

In 2025, drug approvals widen treatment options for chronic diseases, infections and pain, including Ozempic kidney ...

Arrivals of the twice-yearly PrEP option in Eswatini and Zambia mark an important milestone in the goal of ending the HIV epidemic in sub-Saharan Africa “The arrivals of the first doses of lenacapavir ...

A group often forgotten about in the discussion of HIV – despite research pointing to an ongoing crisis – is Black women in the South. Why?

Citi Annual Global Healthcare Conference 2025 December 2, 2025 11:15 AM ESTCompany ParticipantsAndrew Dickinson - ...

Antonio Urbina, MD, the medical director for the Mount Sinai Institute for Advanced Medicine 7th Avenue clinic in New York City, spoke about the advancements made in HIV treatment over the past decade ...

With World Acquired Immunodeficiency Syndrome Day approaching Dec. 1, it’s important to learn about some of the prevention methods and efforts. Besides correctly and consistently using safer sex ...